NTEC – Intec Pharma Ltd. Ordinary Shares

NTEC Feed This feed is responsible for generating the rss feed related to the topic ntec

1 thought on “NTEC – Intec Pharma Ltd. Ordinary Shares”

  1. Intec Pharma Ltd. (NASDAQ: NTEC ) shares closed up 30% to $5.96 following news of a reverse merger with Decoy Biosystems, Inc., a privately-held, preclinical-stage biotech company.
    Decoy stockholders are expected to own 75% of the combined company, while Intec shareholders will own 25%.

Leave a Reply

Your email address will not be published. Required fields are marked *